Source:http://linkedlifedata.com/resource/pubmed/id/18847482
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2008-10-17
|
pubmed:abstractText |
Exacerbations are a major cause of morbidity and mortality in chronic obstructive pulmonary disease. Exacerbations can be of bacterial, viral or mixed etiology, with bacteria involved in 50% of exacerbations. Consequently, current management of exacerbations frequently involves the use of antibiotics. The paper by Puhan et al published this month in BMC Medicine examines the benefit of antibiotics in placebo-controlled trials in mild to moderate outpatient exacerbations. The authors use a meta-analytic approach and rightly conclude that more trials are needed in this area. However, the heterogeneity of chronic obstructive pulmonary disease patients and exacerbations and the limited end-points in past trials do not allow firm conclusions to be drawn about antibiotic use in outpatient exacerbations based on this meta-analysis. Future trials need to take into account this heterogeneity as well as incorporate novel end-points to address this important issue.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-11273797,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-11281745,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-11488328,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-12017408,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-15006954,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-1589668,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-16113422,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-16449273,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-17573508,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-18847478,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-3492164,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18847482-7570411
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1741-7015
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
29
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading | |
pubmed:year |
2008
|
pubmed:articleTitle |
The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et al.
|
pubmed:affiliation |
Division of Pulmonary, Critical Care and Sleep Medicine, University at Buffalo, State University of New York and VA Western New York Healthcare System, Buffalo, New York, USA. ssethi@buffalo.edu
|
pubmed:publicationType |
Editorial,
Comment
|